Daily Archives: November 10, 2016
New promises from targeting stromal-cancer cell crosstalk in glioblastoma
Glioblastoma (GB) is the most frequent primary brain tumor in adults. The prognosis of GB is poor: median survival time is less than one year since the diagnosis and patients usually die within two years. Standard therapy,
Children with ADHD may benefit from following healthy behaviors
A new study shows that children with Attention Deficit and Hyperactivity Disorder follow fewer healthy lifestyle behaviors than non-ADHD youth, suggesting that they may benefit from improving lifestyle choices such as increasing water consumption, decreasing screen time
Discovery of potential anti-breast cancer agents dual targeting ER and VEGFR-2
Breast cancer (BC) is the most common cancer in females worldwide. Among all BC patients, more than 70% are diagnosed as estrogen receptor positive (ER+). Estrogen is the primary female hormone which is responsible for the development
Ventral medial prefrontal cortex: is it a brain target for drug-seeking control?
A weak direct current applied non-invasively (transcranial Direct Current Stimulation – tDCS) over the scalp in both sides over the frontal lateral region of the head, corresponding to what it is called as the dorsolateral prefrontal cortex,
ImmunoTX Summit, on February 6-7, 2017 in San Diego, CA
Organizer: GTCbio Start date: February 6th, 2017 End date: February 7th, 2017 We invite you to GTCbio’s ImmunoTX Summit, which takes place on February 6-7, 2017 in San Diego, CA. The summit will bring together our usual
